SCHEMBL5204028

SCHEMBL5204028

O=C(O)Cc1ccc2cc(Br)n(C3CCN(CCc4cccc(Cl)c4)CC3)c2c1

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.42
OPRM1 P35372 2/20 0.41
HTR1A P08908 1/20 0.41
SLC6A4 P31645 1/20 0.41
CCR5 P51681 1/20 0.41
DRD2 P14416 2/20 0.39
DRD4 P21917 2/20 0.39
POLB P06746 1/20 0.39
DRD3 P35462 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
KCNH2 Q12809 1/20 0.38
CACNA1G O43497 1/20 0.37
CACNA1H O95180 1/20 0.37
CCR4 P51679 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5206848 0.91 SIGMAR1 (0.44) SIGMAR1OPRM1HTR1ASLC6A4CCR5
SCHEMBL5204477 0.91 KCNH2 (0.42) SIGMAR1OPRM1HTR1ASLC6A4DRD2
SCHEMBL5207344 0.89 CACNA1G (0.49) SIGMAR1OPRM1CCR5CACNA1GCACNA1H
SCHEMBL5204772 0.85 KCNH2 (0.41) SIGMAR1OPRM1HTR1ASLC6A4DRD4
SCHEMBL5201930 0.85 HTR2A (0.47) OPRM1
SCHEMBL5204295 0.81 OPRM1 (0.40) SIGMAR1OPRM1CCR5DRD2KCNH2
SCHEMBL5204747 0.81 CACNA1G (0.49) SIGMAR1OPRM1CCR5CACNA1GCACNA1H
SCHEMBL5201956 0.81 KCNH2 (0.43) SIGMAR1OPRM1HTR1ASLC6A4DRD2
SCHEMBL5205196 0.77 HTR2A (0.47) OPRM1
SCHEMBL5204779 0.77 AKR1B1 (0.38) SIGMAR1OPRM1DRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1179532-B1 PROCESS FOR THE PRODUCTION OF INDOLE DERIVATIVES AND INTERMEDIATES THEREFOR EISAI R&D MAN CO LTD (JP) 2007-06-13 EP disclosed
US-6573384-B1 1,4-substituted cyclic amine compound which is useful as a pharmaceutical, and an intermediate for the process EISAI CO., LTD. (JP) 2003-06-03 US disclosed
EP-1179532-A1 PROCESS FOR THE PRODUCTION OF INDOLE DERIVATIVES AND INTERMEDIATES THEREFOR Eisai Co., Ltd. (JP) 2002-02-13 EP disclosed